Business Wire

Powering Precision Health Announces Inaugural European Summit in Amsterdam December 12-13, 2018

Del

Powering Precision Health (PPH), the first innovation-driven summit focused on precision health, today announced much-anticipated details for its 2018 summit, which will take place in Amsterdam Dec. 12-13.

Led by life sciences executive Kevin Hrusovsky, PPH is a non-profit organization made possible through the contributions of a wide range of sponsors committed to disrupting healthcare with innovations enabling safer, less invasive and more effective personalized drugs and treatments, as well as ultra-early detection technologies to identify diseases during their earliest, most treatable stages. The summit explores technologies and advances that can be used to identify and manage environmental disease triggers, catalyzing the promise for disease prevention and furthering strategies for slowing disease progression through lifestyle modifications and other techniques. The summit attracts renowned medical leaders, innovators, investors and advocates who are focused on advancing precision health.

“This is our first PPH summit to be held in Europe and will focus primarily on disruptive digital biomarker strategies for oncology and neurodegeneration,” said Kevin Hrusovsky, PPH Founder and Chairman. “The FDA has recently issued guidance on using biomarkers as surrogate endpoints for disease progression and is proactively utilizing fast-track approval processes for innovative diagnostics that transform medicine, particularly if they focus on high-priority diseases such as cancer and neurodegeneration. Blood-based digital biomarkers are unveiling a sea of new opportunities for seeing disease earlier, long before symptoms or when imaging is unable to detect it, opening up a vast opportunity to revolutionize new strategies for drug development, patient drug response monitoring and early detection.”

A new field of “on-therapy diagnostics” is emerging as a technique to rapidly determine if patients respond to drug therapies and treatments and if not, enabling quick intervention to alternative therapies. There is a mounting body of evidence from numerous medical innovators that digital biomarkers can play a disruptive role in most of these emerging approaches. At the summit, top thought leaders in the field of neurodegeneration will review data obtained with a highly sensitive serum Neurofilament light (NfL) assay as an early indicator of neuronal damage, with particularly compelling data on Multiple Sclerosis (MS) patients. Early information will also be shared about a major ground-breaking concussion study underway including football players at 21 major U.S. universities. In addition, top oncology thought leaders will explore similar digital biomarker techniques for measuring baseline movements of cytokines in blood, as an early indicator of efficacy or toxicity response.

A special breakout session will be held on the morning of Dec. 13 for NfL specifically, given the emerging importance of this biomarker, which could be relevant as a surrogate endpoint for 15 different MS drugs totaling more than $22B in sales each year, as well as 63 MS drug trials already underway. Quanterix’ ultrasensitive serum NfL assay, currently deployed in many drug trials and undergoing a major global analytical validation study with many pharmaceutical and biotechnology companies, will be reviewed during the breakout session.

Thanks to the incredible generosity of multiple sponsors, including Novartis, Quanterix, JP Morgan, Canaccord Genuity, Cowen Group, Leerink, Mintz Levin, and Avison Young, this year’s event is completely free to all participants. However, space is limited so an invitation must be requested here by anyone interested in attending. Learn more about the Powering Precision Health movement and the 2018 summit here.

“If you’re an innovator, investor or part of a patient advocacy group who cares about these diseases, you should be at PPH 2018,” continued Hrusovsky. “In fact, if you or anyone you know has been impacted by cancer, a concussion or neurodegenerative conditions like Alzheimer’s or MS, this should be a must-attend event for you!”

Hrusovsky’s opening keynote address will be recorded and available here for listening shortly after the conclusion of the summit.

About Powering Precision Health

Powering Precision Health is the world's first independent, non-profit organization dedicated to bringing the world's leading physicians, scientists, innovators, investors and patient advocates together to unveil their latest research on new biomarkers that are revolutionizing precision health. Founded by Kevin Hrusovsky, a widely acclaimed thought leader and visionary in life sciences and personalized medicine, Powering Precision Health is a movement that represents the intersection of new technological capabilities with the latest medical research. It’s rooted in the science of precision medicine, which shows personalized treatments to be an increasingly more effective way to maximize drug efficacy and minimize toxicity. In addition to the impact environmental and lifestyle factors can have on minimizing disease triggers, precision health marks an evolution in the way we approach disease and aims to inspire a full healthcare transformation, from philosophy to approach to outcome. In an industry often plagued by skepticism and marred by false promises, PPH puts science first and brings together stakeholders that span from fundamental research to clinical practice, investors, policy makers, patient advocacy groups, and anyone who embraces the vision of Powering Precision Health. Featuring a distinguished keynote lineup of dignitaries, the summit unveils groundbreaking approaches to prevention, early diagnosis, and next-generation treatments. Powering Precision Health is supported thanks to the generous contributions of sponsors from a wide range of companies and organizations committed to advancing precision health.

Twitter (@PPHSUMMIT): https://twitter.com/PPHSUMMIT

LinkedIn: https://www.linkedin.com/company/powering-precision-health/

Contact information

Lindsay Poole, 617-502-4300
Pan.quanterix@pancomm.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 20:00:00 CESTPressemelding

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol

ITechLaw Publishes New Book and Opens Global Public Comment Period on Draft Principles for Responsible Artificial Intelligence23.5.2019 19:11:00 CESTPressemelding

The International Technology Law Association (ITechLaw) has published Responsible AI: A Global Policy Framework, a new book that provides an in-depth review and eight discussion principles that address some of the hottest technology and moral issues of responsible development, deployment and use of artificial intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190523005752/en/ ITechLaw releases new book, Responsible AI: A Global Policy Framework, and opens public comment period. (Photo: Business Wire) Written by a multi-disciplinary group of 54 technology law experts, industry representatives and researchers from 16 countries, the book offers an actionable framework built on the following principles: Ethical Purpose and Societal Benefit, Accountability, Transparency and Explainability, Fairness and Non-discrimination, Safety and Reliability, Open Data and Fair Competition, Privacy, and AI and Intellectual Property.

Kumulus Vape, the 100% Online E-Cigarette Specialist, Goes Public23.5.2019 16:49:00 CESTPressemelding

Kumulus Vape (ISIN FR0013419876 – MLVAP ), an online retailer specialised in the sale of electronic cigarettes and related products (devices, e-liquid and accessories), referred collectively as “e-cigarettes”, is pleased to announce the listing of its shares on the Euronext Access™ compartment in Paris by technical admission (Euronext notice PAR_20190523_05573_ACC). First listing will take place on 28 May 2019. This initial public offering - a first in Europe’s e-cigarette space - is a new milestone in the performance trajectory of the Lyon-based company, a pioneer on this market in acceleration phase. Kumulus Vape posted 2018 sales of €6.5 million, up 116% on 2017. Its outlook is highly auspicious, with 96% quarter-on-quarter growth in the first quarter of 2019. Kumulus Vape’s goal is clear: to become one of the French leaders in 100% online e-cigarette retail within three years. AN E-CIGARETTE PIONEER A CATALOGUE OF OVER 6,000 REFERENCES Kumulus Vape is one of the top online French r

Andersen Global Expands UK Locations23.5.2019 13:30:00 CESTPressemelding

Claritas Tax Limited, a Birmingham, United Kingdom-based collaborating firm of Andersen Global, has opened a new office location in Deansgate, Manchester city center. This means that Andersen Global now has a presence in six locations in the UK through its member firms and collaborating firms. “Now more than ever, it’s important that businesses have easy access to quality advice in the UK’s dynamic political and business environment. The addition of another location in the region adds to our existing capabilities and will allow us to continue providing best-in-class service,” said Mark Vorsatz, Andersen Global Chairman and CEO of Andersen Tax LLC. Founded in 2012, Claritas Tax Limited has a list of clientele from entrepreneurial, privately owned, venture capital, and private equity owned businesses, listed companies and stakeholders. Claritas provides a broad range of tax consulting services, including all aspects of M&A and transactional taxes, R&D and Intellectual Property claims, sh

Mindbreeze Receives Attestation in Accordance with BSI Cloud Requirements23.5.2019 13:11:00 CESTPressemelding

Mindbreeze receives attestation for its Mindbreeze InSpire SaaS service according to the specifications of the C5 catalogue of requirements (Cloud Computing Compliance Controls Catalogue, abbreviated C5), published by the German Federal Office for Information Security (BSI). The Mindbreeze InSpire SaaS service is professionally operated in Mindbreeze data centers on behalf of the customers. The attestation was issued by KPMG Alpen-Treuhand GmbH Wirtschaftsprüfungs- und Steuerberatungsgesellschaft. “The number of cloud services in the field of data analysis is growing steadily. This makes it all the more essential for customers to take a closer look at the choice of suppliers. C5 provides the regulatorily defined IT security level, which is comparable to the IT basic protection level that is increased by cloud controls,” explains Klaus Schatz, Managing Director of KPMG Advisory GmbH. C5 attestation (ISAE 3000 Report Type 2) is a recognized and authoritative verification for all customer